Latest News
ODYSSEY trial finds dolutegravir-based HIV treatment is better for babies
The anti-HIV drug dolutegravir, given in combination with other anti-HIV drugs, improves outcomes for babies and young children living with HIV, compared to standard anti-HIV treatment combinations.
UNITE4TB partnership launches
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
New results confirm the benefit of arthritis drugs in hospitalised patients with COVID-19
New results confirm the benefit of arthritis drugs in hospitalised patients with COVID-19
2021 ASCO Annual Meeting
This Friday marks the beginning of the 2021 ASCO Annual meeting, where MRC Clinical Trials Unit at UCL will be presenting results from colorectal and prostate cancer trials.
MRC CTU at UCL announces the first prospective and collaborative approach to aggregate data meta-analysis
FAME, our new framework for prospective, adaptive meta-analysis (FAME), can help produce more timely, thorough, and reliable systematic reviews of aggregate data.